SARS-COV-2 RESPIRATORY COMPREHENSIVE PANEL Test
Test Name: SARS-COV-2 RESPIRATORY COMPREHENSIVE PANEL Test
Components:
- Sars-Cov-2 RT-PCR
- CBC
- NLR
- CRP
- H1N1 Qualitative RT PCR
- Respiratory Comprehensive Panel
Price: 4910.0 AED
Sample Condition:
Submit Oropharyngeal and Nasopharyngeal Swabs inoculated in special viral transport medium (VTM) available from LPL. Ship refrigerated in a special transport box available from LPL. Duly filled Covid-19 Clinical Information Form (Form 44) / SRF ID as mandated by GOI is mandatory & Duly filled Swine Flu/H1N1 Clinical information form (Form 25) is mandatory AND 2 mL (0.5 mL min.) serum from 1 SST AND 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Overnight fasting is preferred.
Report Delivery: SampleMon / Wed / Fri by 9 am; Report Tue / Thu / Sat
Method: Real Time RT-PCR, Real Time PCR, Immunuturbidimetry, Electrical Impedence, VCS
Test Type: Infections
Doctor: Physician
Test Department:
Pre Test Information: Duly filled Covid-19 Clinical Information Form (Form 44) / SRF ID as mandated by GOI is mandatory & Duly filled Swine Flu/H1N1 Clinical information form (Form 25) is mandatory. Overnight fasting is preferred.
Test Details
The SARS-CoV-2 Respiratory Comprehensive Panel test is a diagnostic test used to detect the presence of the SARS-CoV-2 virus, which is responsible for causing COVID-19. This test is specifically designed to detect the virus in respiratory samples, such as nasal swabs or throat swabs.
The panel test typically includes multiple components, including:
- Nucleic Acid Amplification Test (NAAT): This test uses a technique called polymerase chain reaction (PCR) to amplify and detect specific genetic material (RNA) of the SARS-CoV-2 virus. It can identify the presence of the virus even at low levels.
- Gene Target Detection: The test targets specific genes of the SARS-CoV-2 virus, such as the N gene or the E gene, to confirm the presence of the virus. These genes are unique to the virus and are not found in other common respiratory viruses.
- Viral Load Quantification: Some panel tests also include a viral load quantification component, which measures the amount of viral genetic material present in the sample. This can help determine the severity of the infection and guide treatment decisions.
- Variant Detection: Some panel tests can also detect specific variants or mutations of the SARS-CoV-2 virus, such as the Delta variant or the Alpha variant. This information can be useful in tracking the spread of different variants and assessing their potential impact on public health.
The SARS-CoV-2 Respiratory Comprehensive Panel test is typically performed in a laboratory setting and requires specialized equipment and trained personnel. The results of the test can help healthcare providers diagnose COVID-19, monitor the progression of the infection, and guide appropriate treatment and isolation measures.
Test Name | SARS-COV-2 RESPIRATORY COMPREHENSIVE PANEL Test |
---|---|
Components | *Sars-Cov-2 RT-PCR*CBC*NLR*CRP*H1N1 Qualitative RT PCR *Respiratory Comprehensive Panel |
Price | 4910.0 AED |
Sample Condition | Submit Oropharyngeal and Nasopharyngeal Swabs inoculated in special viral transport medium (VTM) available from LPL. Ship refrigerated in a special transport box available from LPL. Duly filled Covid-19 Clinical Information Form (Form 44) \/ SRF ID as mandated by GOI is mandatory & Duly filled Swine Flu\/H1N1 Clinical information form (Form 25) is mandatory AND 2 mL (0.5 mL min.) serum from 1 SST AND 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Overnight fasting is preferred. |
Report Delivery | SampleMon / Wed / Fri by 9 am; Report Tue / Thu / Sat |
Method | Real Time RT-PCR, Real Time PCR, Immunuturbidimetry, Electrical Impedence, VCS |
Test type | Infections |
Doctor | Physician |
Test Department: | |
Pre Test Information | Duly filled Covid-19 Clinical Information Form (Form 44) / SRF ID as mandated by GOI is mandatory & Duly filled Swine Flu/H1N1 Clinical information form (Form 25) is mandatory. Overnight fasting is preferred. |
Test Details |
The SARS-CoV-2 Respiratory Comprehensive Panel test is a diagnostic test used to detect the presence of the SARS-CoV-2 virus, which is responsible for causing COVID-19. This test is specifically designed to detect the virus in respiratory samples, such as nasal swabs or throat swabs. The panel test typically includes multiple components, including: 1. Nucleic Acid Amplification Test (NAAT): This test uses a technique called polymerase chain reaction (PCR) to amplify and detect specific genetic material (RNA) of the SARS-CoV-2 virus. It can identify the presence of the virus even at low levels. 2. Gene Target Detection: The test targets specific genes of the SARS-CoV-2 virus, such as the N gene or the E gene, to confirm the presence of the virus. These genes are unique to the virus and are not found in other common respiratory viruses. 3. Viral Load Quantification: Some panel tests also include a viral load quantification component, which measures the amount of viral genetic material present in the sample. This can help determine the severity of the infection and guide treatment decisions. 4. Variant Detection: Some panel tests can also detect specific variants or mutations of the SARS-CoV-2 virus, such as the Delta variant or the Alpha variant. This information can be useful in tracking the spread of different variants and assessing their potential impact on public health. The SARS-CoV-2 Respiratory Comprehensive Panel test is typically performed in a laboratory setting and requires specialized equipment and trained personnel. The results of the test can help healthcare providers diagnose COVID-19, monitor the progression of the infection, and guide appropriate treatment and isolation measures. |